Skip to main content
. 2022 Oct 14;10:1016853. doi: 10.3389/fpubh.2022.1016853

Table 1.

Baseline characteristics of study participants.

Characteristics Overall (n = 22,702) Tertiles of blue days (days/year) P value
Worst tertile Middle tertile Best tertile
3.7–42.0 (n = 7,426) 42.0–77.4 (n = 6,962) 77.4–122.3 (n = 8,314)
Age, years 56.1 ± 13.1 56.2 ± 13.4 57.5 ± 12.4 54.9 ± 13.3 <.001
Male 10,505 (46.3) 3,512 (47.3) 2,946 (42.3) 4,047 (48.7) <.001
Urban 10,130 (44.6) 4,090 (55.1) 2,530 (36.3) 3,510 (42.2) <.001
Han ethnicity 20,315 (89.5) 7,360 (99.1) 5,342 (76.7) 7,613 (91.6) <.001
Region <.001
 East 9,263 (40.8) 3,167 (42.6) 2,120 (30.5) 3,976 (47.8)
 Central 9,460 (41.7) 4,259 (57.4) 1,899 (27.3) 3,302 (39.7)
 West 3,979 (17.5) 0 (0) 2,943 (42.2) 1,036 (12.5)
Education at least middle school 11,109 (48.9) 3,783 (50.9) 3,348 (48.1) 3,978 (47.8) <.001
Smoking <.001
 Current 5,731 (25.2) 1,878 (25.3) 1,582 (22.7) 2,271 (27.3)
 Former 1,216 (5.4) 313 (4.2) 450 (6.5) 453 (5.4)
 Never 15,755 (69.4) 5,235 (70.5) 4,930 (70.8) 5,590 (67.2)
Alcohol consumption 6,318 (27.8) 1,893 (25.5) 1,743 (25.0) 2,682 (32.3) <.001
BMI (kg/m2) <.001
 Normal 10,213 (45.0) 3,156 (42.5) 2,994 (43.0) 4,063 (48.9)
 Overweight 8,533 (37.6) 2,891 (38.9) 2,663 (38.3) 2,979 (35.8)
 Obesity 3,956 (17.4) 1,379 (18.6) 1,305 (18.7) 1,272 (15.3)
Hypertension 8,957 (39.5) 2,914 (39.2) 3,044 (43.7) 2,999 (36.1) <.001
Hypercholesterolemia 7,724 (34.0) 2,221 (29.9) 2,488 (35.7) 3,015 (36.3) <.001
Diabetes mellitus 2,286 (10.1) 706 (9.5) 840 (12.1) 740 (8.9) <.001
Family history of CVD 2,621 (11.5) 793 (10.7) 791 (11.4) 1,037 (12.5) <.001
CVD medication history 4,929 (21.7) 1,577 (21.2) 1,892 (27.2) 1,460 (17.6) <.001
Ambient temperature, (°C) 24.6 ± 4.3 26.8 ± 2.4 22.2 ± 5.7 24.7 ± 3.1 <.001
PM2.5, (μg/m3) 61.7 ± 22.5 70.8 ± 25.2 59.0 ± 23.9 55.9 ± 15.1 <.001
NO2, (μg/m3) 29.3 ± 13.3 33.7 ± 11.1 26.8 ± 18.4 27.4 ± 8.1 <.001
O3, (μg/m3) 56.7 ± 10.4 56.7 ± 10.7 57.1 ± 10.8 56.3 ± 9.8 <.001

Numbers are mean ± SD or no. (%). BMI, body mass index; CVD, cardiovascular disease; PM2.5, particles with an aerodynamic diameter of ≤ 2.5 μm; NO2, nitrogen dioxide; O3, ozone.